SCHEMBL9531475

SCHEMBL9531475

CC(C)CCc1c(F)n(CC(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 4/20 0.37
AGTR2 P50052 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9036076 0.94 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9553875 0.93 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9036980 0.93 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL9529721 0.93 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9553812 0.91 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9036832 0.91 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9037043 0.91 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9553891 0.90 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL9554229 0.90 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL9530183 0.90 AGTR1 (0.38) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed